Esophagectomy versus endoscopic resection for patients with early-stage esophageal adenocarcinoma: A National Cancer Database propensity-matched study
- PMID: 29455958
- DOI: 10.1016/j.jtcvs.2017.11.111
Esophagectomy versus endoscopic resection for patients with early-stage esophageal adenocarcinoma: A National Cancer Database propensity-matched study
Abstract
Objectives: Endoscopic resection has been rapidly adopted in the treatment of early-stage esophageal tumors. We compared the outcomes after esophagectomy or endoscopic resection for stage T1a adenocarcinoma.
Methods: We queried the National Cancer Database for patients with T1a esophageal adenocarcinoma who underwent esophagectomy or endoscopic resection and generated a balanced cohort with 735 matched pairs using propensity-score matching. We then performed a multivariable Cox regression analysis on the matched and unmatched cohorts.
Results: We identified 2173 patients; 1317 (60.6%) underwent esophagectomy, and 856 (39.4%) underwent endoscopic resection. In the unmatched cohort, patients who underwent esophagectomy were younger, more often not treated in academic settings, and more likely to have comorbidities (30.4% vs 22.5%, P = .002). They had longer hospital stays and more readmissions than patients who underwent endoscopic resection. Factors positively affecting overall survival were younger age, resection at an academic medical center, and lower Charlson-Deyo comorbidity score. In the matched cohort, patients who underwent esophagectomy had longer hospital stays and were more likely to be readmitted within 30 days (7.0% vs 0.6%, P < .001). When a time period-specific partition was applied, endoscopic resection had a lower death hazard 0 to 90 days after resection (hazard ratio, 0.15; P = .003), but this was reversed for survival greater than 90 days (hazard ratio, 1.34; P = .02).
Conclusions: In patients with early-stage esophageal adenocarcinoma, survival appears equivalent after endoscopic resection or esophagectomy, but endoscopic resection is associated with shorter hospital stays, fewer readmissions, and less 90-day mortality. In patients surviving more than 90 days, esophagectomy may provide better overall survival.
Keywords: endoscopic resection; esophageal cancer; esophagectomy.
Copyright © 2018 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.
Comment in
-
Esophagectomy versus endoscopic resection for patients with early-stage adenocarcinoma: Mercedes versus Tesla.J Thorac Cardiovasc Surg. 2018 May;155(5):2209-2210. doi: 10.1016/j.jtcvs.2017.12.104. Epub 2018 Jan 5. J Thorac Cardiovasc Surg. 2018. PMID: 29395206 No abstract available.
-
Endoscopic mucosal resection: The new gold standard or the "Bitcoin" of the present.J Thorac Cardiovasc Surg. 2018 May;155(5):2219-2220. doi: 10.1016/j.jtcvs.2017.12.094. Epub 2018 Jan 4. J Thorac Cardiovasc Surg. 2018. PMID: 29395209 No abstract available.
-
Discussion.J Thorac Cardiovasc Surg. 2018 May;155(5):2217-2218. doi: 10.1016/j.jtcvs.2017.11.121. Epub 2018 Feb 15. J Thorac Cardiovasc Surg. 2018. PMID: 29455963 No abstract available.
Similar articles
-
Does delayed esophagectomy after endoscopic resection affect outcomes in patients with stage T1 esophageal cancer? A propensity score-based analysis.Surg Endosc. 2018 Mar;32(3):1441-1448. doi: 10.1007/s00464-017-5830-4. Epub 2017 Sep 15. Surg Endosc. 2018. PMID: 28916920
-
Outcomes after endoscopic mucosal resection or esophagectomy for submucosal esophageal adenocarcinoma.J Thorac Cardiovasc Surg. 2018 Jul;156(1):406-413.e3. doi: 10.1016/j.jtcvs.2018.02.093. Epub 2018 Mar 12. J Thorac Cardiovasc Surg. 2018. PMID: 29605441
-
Using the National Cancer Database to create a scoring system that identifies patients with early-stage esophageal cancer at risk for nodal metastases.J Thorac Cardiovasc Surg. 2017 Nov;154(5):1787-1793. doi: 10.1016/j.jtcvs.2017.07.036. Epub 2017 Jul 29. J Thorac Cardiovasc Surg. 2017. PMID: 28867381
-
Endoscopic versus surgical therapy for Barrett's esophagus neoplasia.Expert Rev Gastroenterol Hepatol. 2015 Jan;9(1):31-5. doi: 10.1586/17474124.2014.934674. Epub 2014 Aug 27. Expert Rev Gastroenterol Hepatol. 2015. PMID: 25160753 Review.
-
What Constitutes Optimal Management of T1N0 Esophageal Adenocarcinoma?Ann Surg Oncol. 2019 Mar;26(3):714-731. doi: 10.1245/s10434-018-07118-5. Epub 2019 Jan 3. Ann Surg Oncol. 2019. PMID: 30607765 Review.
Cited by
-
Trends in Treatment of T1N0 Esophageal Cancer.Ann Surg. 2019 Sep;270(3):434-443. doi: 10.1097/SLA.0000000000003466. Ann Surg. 2019. PMID: 31274653 Free PMC article.
-
Association of survival with adjuvant radiotherapy for pN0 esophageal cancer.Aging (Albany NY). 2023 Apr 25;15(8):3158-3170. doi: 10.18632/aging.204677. Online ahead of print. Aging (Albany NY). 2023. PMID: 37184977 Free PMC article.
-
Current status of esophageal cancer treatment.Chin J Cancer Res. 2020 Jun;32(3):271-286. doi: 10.21147/j.issn.1000-9604.2020.03.01. Chin J Cancer Res. 2020. PMID: 32694894 Free PMC article.
-
Adjuvant radiotherapy for patients with pathologic node-negative esophageal carcinoma: A population based propensity matching analysis.Thorac Cancer. 2020 Feb;11(2):243-252. doi: 10.1111/1759-7714.13235. Epub 2019 Dec 11. Thorac Cancer. 2020. PMID: 31828980 Free PMC article.
-
The effect of age on survival after endoscopic resection versus surgery for T1a esophageal cancer.J Thorac Cardiovasc Surg. 2020 Jul;160(1):295-302.e3. doi: 10.1016/j.jtcvs.2019.11.050. Epub 2019 Dec 2. J Thorac Cardiovasc Surg. 2020. PMID: 31928824 Free PMC article.
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical